Release date: 2015-09-28 According to the Digital Trends website, the online version of Wired said that Japanese pharmaceutical manufacturer Otsuka Pharmaceutical is developing drugs that will ensure patients are prescribed according to their doctor's advice. This is a new type of digital medicine that uses sensor technology in prescription drugs. Otsuka Pharmaceutical has been testing digital drug technology in a series of trials using its highly regarded psychotropic drug aripiprazole. Otsuka Pharmaceuticals embeds a microchip in the drug, and the drug is easily detected when it is taken by the patient. An application developed by California medical technology manufacturer Proteus to detect drugs and confirm that the drugs have been taken by patients. If the patient does not take the medicine, the application will alert the doctor. Source: Tencent Digital Chewy Candies,Soft Chews Candy,Chewy Fruit Candy,Best Chewy Candy JINJIANG XIEXIANG TRADE CORP., LTD. , http://www.xiexiangfoodstuff.com
According to Digital Trends, the sensor system uses trace amounts of magnesium and copper – included in the drug. When exposed to stomach acid, the two metal elements produce a weak voltage that can be detected by sensors that are close to the patient's skin. Upon receipt of the signal, the sensor sends a message to the Proteus application running on the phone. The app can share information with the doctor – of course, with the patient's consent.
The US Food and Drug Administration ("FDA") has separately approved drugs and sensor systems. Currently, the FDA plans to evaluate the use of the two. Although aripiprazole was used in the test, the Proteus chip and sensor system is suitable for any drug and is currently being tested with drugs for the treatment of diabetes and hypertension. Digital Trends pointed out that if approved, the system could open the curtain of digital medicine and lay the foundation for other companies to use drug-based sensors in novel ways.